About this trial
Patients living with diabetes mellitus have double the risk of kidney failure compared to patients without diabetes following use of dye in many x-rays and procedures to diagnose and treat narrowing of the arteries (blood vessels) in the heart that can lead to angina or a heart attack. Heart disease is the commonest cause of death in patients with diabetes. People with diabetes are more likely to need these tests/treatments. By identifying those at greater risk of kidney complications we may be able to make these tests/treatments safer and offer them to more patients with diabetes.
Eligibility criteria
Qualifiers
Age > 18 years, known diabetes mellitus or BM on arrival consistent with probable diagnosis of diabetes, eGFR <60 ml/min
Undergoing a PCI procedure
Agrees to the additional collection of blood and urine samples as outlined above
Agrees to access of their clinical records for the collection of relevant medical data
Disqualifiers
Cardiogenic shock
Pregnancy
Patient on renal replacement therapy (haemodialysis/CAPD/renal transplant)
Known clinically significant infection such as HIV, Hepatitis or TB
Trial design
Treatments tested in this trial
- Not listed